InMode (INMD) Competitors $14.71 -0.47 (-3.10%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$14.73 +0.02 (+0.11%) As of 07/11/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock INMD vs. INSP, NVST, PRCT, LIVN, WRBY, ENOV, NVCR, LMAT, EYE, and CNMDShould you be buying InMode stock or one of its competitors? The main competitors of InMode include Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), Warby Parker (WRBY), Enovis (ENOV), NovoCure (NVCR), LeMaitre Vascular (LMAT), National Vision (EYE), and CONMED (CNMD). These companies are all part of the "medical equipment" industry. InMode vs. Its Competitors Inspire Medical Systems Envista PROCEPT BioRobotics LivaNova Warby Parker Enovis NovoCure LeMaitre Vascular National Vision CONMED Inspire Medical Systems (NYSE:INSP) and InMode (NASDAQ:INMD) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings. Is INSP or INMD more profitable? InMode has a net margin of 44.79% compared to Inspire Medical Systems' net margin of 7.92%. InMode's return on equity of 17.17% beat Inspire Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Inspire Medical Systems7.92% 10.00% 8.68% InMode 44.79%17.17%15.20% Which has stronger valuation & earnings, INSP or INMD? InMode has lower revenue, but higher earnings than Inspire Medical Systems. InMode is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspire Medical Systems$840.11M4.58$53.51M$2.1760.13InMode$394.82M2.36$181.27M$2.336.31 Does the media refer more to INSP or INMD? In the previous week, Inspire Medical Systems had 3 more articles in the media than InMode. MarketBeat recorded 13 mentions for Inspire Medical Systems and 10 mentions for InMode. Inspire Medical Systems' average media sentiment score of 1.22 beat InMode's score of 0.77 indicating that Inspire Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspire Medical Systems 10 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InMode 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, INSP or INMD? Inspire Medical Systems has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500. Comparatively, InMode has a beta of 1.95, suggesting that its share price is 95% more volatile than the S&P 500. Do institutionals and insiders hold more shares of INSP or INMD? 94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by insiders. Comparatively, 6.9% of InMode shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts rate INSP or INMD? Inspire Medical Systems currently has a consensus target price of $211.91, indicating a potential upside of 62.41%. InMode has a consensus target price of $18.54, indicating a potential upside of 26.05%. Given Inspire Medical Systems' stronger consensus rating and higher probable upside, research analysts clearly believe Inspire Medical Systems is more favorable than InMode.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73InMode 0 Sell rating(s) 7 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.13 SummaryInspire Medical Systems beats InMode on 9 of the 16 factors compared between the two stocks. Get InMode News Delivered to You Automatically Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INMD vs. The Competition Export to ExcelMetricInModeMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$929.80M$10.47B$5.56B$9.10BDividend YieldN/A2.09%5.06%4.02%P/E Ratio6.3117.1228.2620.26Price / Sales2.3630.05427.70153.06Price / Cash8.0722.5637.1257.67Price / Book1.453.668.045.49Net Income$181.27M$235.43M$3.19B$250.45M7 Day Performance-2.94%1.27%3.62%4.79%1 Month Performance10.10%5.34%5.98%9.59%1 Year Performance-17.68%-15.78%29.39%16.41% InMode Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INMDInMode4.1264 of 5 stars$14.71-3.1%$18.54+26.0%-17.7%$929.80M$394.82M6.31480News CoveragePositive NewsAnalyst ForecastINSPInspire Medical Systems4.8844 of 5 stars$127.11-1.1%$211.91+66.7%-6.0%$3.75B$802.80M58.581,246News CoveragePositive NewsAnalyst UpgradeNVSTEnvista3.2743 of 5 stars$19.66-3.6%$20.23+2.9%+26.0%$3.33B$2.51B-3.0112,300Analyst ForecastPRCTPROCEPT BioRobotics2.2985 of 5 stars$56.97-1.6%$90.00+58.0%-18.3%$3.15B$224.50M-33.51430News CoverageAnalyst ForecastLIVNLivaNova3.1135 of 5 stars$45.58-1.2%$59.29+30.1%-13.8%$2.49B$1.25B-11.142,900News CoverageWRBYWarby Parker2.47 of 5 stars$21.40-3.8%$22.88+6.9%+37.2%$2.24B$795.09M-178.333,780News CoveragePositive NewsAnalyst DowngradeENOVEnovis2.6083 of 5 stars$33.03-1.8%$58.00+75.6%-26.1%$1.89B$2.15B-2.377,367Analyst ForecastNVCRNovoCure3.6661 of 5 stars$16.89-4.6%$32.83+94.4%-2.1%$1.88B$605.22M-11.191,488Analyst ForecastLMATLeMaitre Vascular2.2802 of 5 stars$82.98-1.7%$97.83+17.9%-2.8%$1.87B$219.86M41.91490News CoverageEYENational Vision2.5514 of 5 stars$23.33-2.4%$18.67-20.0%+93.1%$1.84B$1.82B-70.6913,411News CoverageAnalyst ForecastCNMDCONMED4.4364 of 5 stars$51.86-4.5%$62.20+19.9%-25.1%$1.60B$1.31B13.653,900 Related Companies and Tools Related Companies INSP Alternatives NVST Alternatives PRCT Alternatives LIVN Alternatives WRBY Alternatives ENOV Alternatives NVCR Alternatives LMAT Alternatives EYE Alternatives CNMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INMD) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
